USFDA gives permission to Lupin to market Fluocinonide Topical Solution
DSIJ Intelligence / 24 Jul 2017
Lupin on Monday announced that the company has received the United States Food and Drug Administration (USFDA) approval to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.
Pharmaceutical company Lupin on Monday announced that the company has received the United States Food and Drug Administration (USFDA) approval to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.
This drug is used to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Fluocinonide Topical Solution USP, 0.05% had US sales of USD 32.4 million (IMS MAT March 2017).
At Rs 1,151.25, the stock was trading up by 0.74% on BSE at 1449 hours. It opened today at Rs 1,165.75 per share. It touched its intraday high at Rs 1,174.85 and low at Rs 1,144.50.
It attracted total traded volume of 12,02,379 shares and traded value of 13,871 lakh on NSE at 1,453 hours.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.